Outcome measure
|
Stage
|
Completed
|
Mean
|
SD
|
Min
|
Max
|
---|
Participants
|
ᅟDemQol
|
Baseline
|
10
|
89
|
11
|
72
|
105
|
|
8 weeksa
|
7
|
94
|
7
|
87
|
101
|
|
Post intervention
|
7
|
94
|
12
|
69
|
106
|
ᅟEQ-5D-5L
|
Baseline
|
10
|
0.79
|
0.04
|
0.72
|
0.85
|
|
Post intervention
|
7
|
0.77
|
0.09
|
0.65
|
0.88
|
ᅟPHQ-9
|
Baseline
|
10
|
6
|
6
|
0
|
19
|
|
Post intervention
|
7
|
3
|
3
|
0
|
9
|
ᅟGAD-7
|
Baseline
|
10
|
4
|
5
|
0
|
18
|
|
Post intervention
|
7
|
1
|
1
|
0
|
4
|
ᅟGSE
|
Baseline
|
10
|
27
|
5
|
20
|
36
|
|
Post intervention
|
7
|
25
|
9
|
10
|
34
|
ᅟPSMS
|
Baseline
|
10
|
23
|
0
|
23
|
23
|
|
Post intervention
|
7
|
23
|
0
|
23
|
24
|
ᅟIADL
|
Baseline
|
10
|
6
|
2
|
2
|
8
|
|
Post intervention
|
7
|
6
|
2
|
3
|
8
|
Carer
|
ᅟEQ-5D-5L
|
Baseline
|
7
|
0.81
|
0.30
|
0.16
|
1.00
|
|
Post intervention
|
5
|
0.75
|
0.38
|
0.09
|
1.00
|
ᅟPHQ-9
|
Baseline
|
7
|
5
|
6
|
0
|
15
|
|
Post intervention
|
5
|
7
|
10
|
0
|
23
|
ᅟZarit Burden
|
Baseline
|
7
|
16
|
13
|
2
|
40
|
|
Post intervention
|
5
|
24
|
18
|
4
|
52
|
ᅟSCQ
|
Baseline
|
7
|
31
|
6
|
19
|
35
|
|
Post intervention
|
5
|
26
|
8
|
17
|
34
|
- aThe primary outcome, the DemQol, was also repeated at 8-week follow-up